Criteria | Outcome measure | ||
---|---|---|---|
Necrosis yes/no | Depth (SKIN score) | Total necrosis area | |
Subjectivity of measurement (κ [95% CI] for the primary and secondary clinical assessor*) | 0.84 [0.62 to 1.00] | 0.79 [0.58 to 0.99] | 0.57 [0.21 to 0.94] |
Total sample size required to demonstrate statistically significant difference between treatment and control group (based on observed data)† | 1096 | 1556 | 2866 |
Proportion of patients with observed response** | 95.0% | 89.4% | 88.7% |